Ileocecal Ulceration and Recurrent Bleeding in a Young Man With Oral Ulcers

A 27-year-old man arrived with intermittent abdominal pain stretching across 3 years, a history already complicated by recurrent oral ulcers. The combination immediately pointed toward an inflammatory ulcerative disorder rather than simple functional pain, and the laboratory profile matched that concern: C-reactive protein was 22.31 mg/L, erythrocyte sedimentation rate 25 mm/hour, and haemoglobin had fallen to 77 g/L. Human Leukocyte Antigen-B51 was negative, but that result did not settle the diagnosis, because intestinal ulcerative disease can still declare itself without that marker.

The most clinically important clue came from the bowel imaging.

Deep Ulceration in the Ileocaecal Region Drove the Initial Diagnosis

CT enterography showed thickened bowel walls in the ileocaecal region, and colonoscopy identified a deep, oval ulcerative lesion with discrete borders in the same area. In a young patient with recurrent oral ulcers, that anatomic pattern is highly concerning because the ileocaecum is a favored site for aggressive inflammatory ulceration, and discrete deep ulcers can bleed, perforate, or resist routine endoscopic therapy. The mucosal injury was not superficial irritation; it was a structural lesion capable of causing major hemorrhage and chronic iron-deficiency or inflammatory anaemia.

Two days after admission, the case stopped being a diagnostic puzzle and became an emergency. Massive gastrointestinal haemorrhage developed, conservative treatment failed, and colonoscopy was unable to control the bleeding. The clinical trajectory reflected a core problem in destructive ileocecal ulceration: when the ulcer base erodes into sizable vessels, local medical management often cannot keep pace with the rate of blood loss. In those settings, hemodynamic risk rises quickly, and definitive source control becomes the only viable option.

Surgery Was Required After Endoscopic and Conservative Measures Failed

The patient ultimately underwent a right hemicolectomy. For an ulcer confined to the ileocaecal region, resection offers the most direct path to stop hemorrhage and remove tissue that has already become refractory to endoscopic hemostasis. The operation also fits the broader surgical reality of severe intestinal ulcer disease: once the lesion is deep, bleeding is massive, and the bowel wall is structurally compromised, bypassing repeated local rescue attempts may prevent further catastrophic blood loss.

Four months later, loop ileostomy takedown was performed. The course then turned again in an alarming direction, because massive bleeding occurred on the twentieth day after loop ileostomy surgery. Emergent colonoscopy showed a new ulcer, confirming that the disease process had not been extinguished by the first resection. In practical terms, the operation controlled one bleeding focus, but it did not abolish the underlying inflammatory tendency to create new ulcers in remaining bowel.

Recurrent Ulcer Formation Kept the Case Clinically Dangerous

This recurrence is the feature that makes the case especially instructive. An isolated surgical lesion can be cured; a systemic ulcerative disorder can return in another segment, and the bleeding risk follows it. The course after ileostomy takedown suggests ongoing mucosal vulnerability and a propensity for new ulcer formation despite prior resection. In a patient with recurrent oral ulcers and ileocecal ulceration, that pattern is strongly compatible with a relapsing inflammatory vasculitic or neutrophilic process, even when serology is not definitive.

HLA-B51 negativity does not eliminate that concern. It simply means the diagnosis cannot rest on one laboratory marker. The endoscopic morphology, the anatomic location, the recurrent oral ulcers, and the hemorrhagic relapses after surgery carry more weight than a single negative test. In bedside terms, the case warns clinicians not to anchor on negative HLA testing when the clinical phenotype is already pointing toward a relapsing ulcerative intestinal disease.

Why Ileocecal Disease Bleeds So Violently

The ileocecal region has a dense vascular supply and is exposed to substantial mechanical stress from intestinal transit. When deep ulceration develops there, the lesion can extend beyond the mucosa into submucosa and deeper layers, where larger vessels are present. Once that happens, brisk lower gastrointestinal bleeding can occur with little warning, and hemoglobin can fall rapidly, as it did here. The pathology also helps explain why colonoscopy may fail: a diffuse or deep ulcer base can be difficult to stabilize endoscopically, especially if the lesion is broad, friable, or repeatedly reactivated by ongoing inflammation.

The patient’s recurrent oral ulcers are not a minor historical detail. In the setting of intestinal ulceration, they provide a systemic clue that the disease is not confined to one bowel segment. Oral aphthae often track with multisite inflammatory activity, and their presence should push clinicians to consider a syndromic diagnosis rather than a purely local colonic lesion.

Persistent Diagnostic Tension Remains After Resection

The case leaves one central clinical issue unresolved in a broader sense: surgical control of hemorrhage did not equal biologic remission. The new ulcer discovered after ileostomy takedown shows how aggressively this disease can recur, and it explains why patients with recurrent oral ulcers and ileocecal ulceration require close postoperative surveillance. For the treating team, the danger is not only acute blood loss but also the return of ulceration in bowel that appears structurally sound until hemorrhage begins again.

In a young man with elevated inflammatory markers, severe anaemia, recurrent oral ulcers, ileocecal deep ulceration, and repeated massive bleeding, the case illustrates the limits of endoscopic rescue and the need for ongoing vigilance after surgery. Negative HLA-B51 testing did not protect against relapse, and the postoperative recurrence demonstrated that the underlying disorder remained active despite resection.


Reporting by Dr. A. Nikhil Krishnan, MBBS for Medicine World Foundation, with additional data provided by Gut (BMJ).